Chemoinformaics analysis of 2-O-beta-L-Arabinofuranosyl-L-arabinose
| Molecular Weight | 282.245 | nRot | 2 |
| Heavy Atom Molecular Weight | 264.101 | nRig | 12 |
| Exact Molecular Weight | 282.095 | nRing | 2 |
| Solubility: LogS | -0.009 | nHRing | 2 |
| Solubility: LogP | -2.827 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 35.9203 |
| nHD | 6 | BPOL | 23.2657 |
| QED | 0.297 |
| Synth | 4.415 |
| Natural Product Likeliness | 1.995 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.84 |
| HIA | 0.968 |
| CACO-2 | -5.761 |
| MDCK | 0.000322438 |
| BBB | 0.51 |
| PPB | 0.11856 |
| VDSS | 0.3 |
| FU | 0.718281 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.03 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.124 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.116 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.004 |
| CL | 1.228 |
| T12 | 0.566 |
| hERG | 0.037 |
| Ames | 0.217 |
| ROA | 0.124 |
| SkinSen | 0.027 |
| Carcinogencity | 0.023 |
| EI | 0.015 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.768504 |